Literature DB >> 11859924

Roles of BCL-2 and caspase 3 in the adenosine A3 receptor-induced apoptosis.

E Appel1, G Kazimirsky, E Ashkenazi, S G Kim, K A Jacobson, C Brodie.   

Abstract

Selective A3 adenosine receptor agonists have been shown to induce apoptosis in a variety of cell types. In this study we examined the effects of adenosine receptor agonists selective for A1, A2A, or A3 receptors on the induction of apoptosis in primary cultures of rat astrocytes and in C6 glial cells. Treatment of the cells with the A3 receptor agonist Cl-IB-MECA (10 microM) induced apoptosis in both cell types. The effects of Cl-IB-MECA were partially antagonized by the A3 receptor-selective antagonist MRS 1191. In contrast, the A1 and A2A receptor agonists, CPA and CGS 21680, respectively, did not have significant effects on apoptosis in these cells. Cl-IB-MECA reduced the expression of endogenous Bcl-2, whereas it did not affect the expression of Bax. Overexpression of Bcl-2 in C6 cells abrogated the induction of apoptosis induced by the A3 agonist. Cl-IB-MECA also induced an increase in caspase 3 activity and caspase inhibitors decreased the apoptosis induced by the A3 agonist. These findings suggest that intense activation of the A3 receptor is pro-apoptotic in glial cells via bcl2 and caspase-3 dependent pathways.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11859924      PMCID: PMC5567771          DOI: 10.1385/JMN:17:3:285

Source DB:  PubMed          Journal:  J Mol Neurosci        ISSN: 0895-8696            Impact factor:   3.444


  22 in total

1.  Identification of a p53-dependent negative response element in the bcl-2 gene.

Authors:  T Miyashita; M Harigai; M Hanada; J C Reed
Journal:  Cancer Res       Date:  1994-06-15       Impact factor: 12.701

2.  Astrocyte activation by Sindbis virus: expression of GFAP, cytokines, and adhesion molecules.

Authors:  C Brodie; N Weizman; A Katzoff; S Lustig; D Kobiler
Journal:  Glia       Date:  1997-04       Impact factor: 7.452

3.  Adenosine A3 receptor agonists protect HL-60 and U-937 cells from apoptosis induced by A3 antagonists.

Authors:  Y Yao; Y Sei; M P Abbracchio; J L Jiang; Y C Kim; K A Jacobson
Journal:  Biochem Biophys Res Commun       Date:  1997-03-17       Impact factor: 3.575

4.  Immediate early up-regulation of bax expression by p53 but not TGF beta 1: a paradigm for distinct apoptotic pathways.

Authors:  M Selvakumaran; H K Lin; T Miyashita; H G Wang; S Krajewski; J C Reed; B Hoffman; D Liebermann
Journal:  Oncogene       Date:  1994-06       Impact factor: 9.867

5.  Adenosine A1 receptor-mediated inhibition of cyclic AMP accumulation in type-2 but not type-1 rat astrocytes.

Authors:  M C Peakman; S J Hill
Journal:  Eur J Pharmacol       Date:  1996-06-13       Impact factor: 4.432

6.  Mediation of the neuroprotective action of R-phenylisopropyl-adenosine through a centrally located adenosine A1 receptor.

Authors:  D G MacGregor; W J Miller; T W Stone
Journal:  Br J Pharmacol       Date:  1993-09       Impact factor: 8.739

Review 7.  Protective mechanisms of adenosine in neurons and glial cells.

Authors:  P Schubert; T Ogata; C Marchini; S Ferroni; K Rudolphi
Journal:  Ann N Y Acad Sci       Date:  1997-10-15       Impact factor: 5.691

8.  Protein kinase C delta (PKCdelta) inhibits the expression of glutamine synthetase in glial cells via the PKCdelta regulatory domain and its tyrosine phosphorylation.

Authors:  C Brodie; K Bogi; P Acs; P S Lorenzo; L Baskin; P M Blumberg
Journal:  J Biol Chem       Date:  1998-11-13       Impact factor: 5.157

9.  The effects of adenosine A3 receptor stimulation on seizures in mice.

Authors:  D K Von Lubitz; M F Carter; S I Deutsch; R C Lin; J Mastropaolo; Y Meshulam; K A Jacobson
Journal:  Eur J Pharmacol       Date:  1995-02-24       Impact factor: 4.432

10.  2-Substitution of N6-benzyladenosine-5'-uronamides enhances selectivity for A3 adenosine receptors.

Authors:  H O Kim; X D Ji; S M Siddiqi; M E Olah; G L Stiles; K A Jacobson
Journal:  J Med Chem       Date:  1994-10-14       Impact factor: 7.446

View more
  11 in total

1.  A3 adenosine receptors in human astrocytoma cells: agonist-mediated desensitization, internalization, and down-regulation.

Authors:  M L Trincavelli; D Tuscano; M Marroni; A Falleni; V Gremigni; S Ceruti; M P Abbracchio; K A Jacobson; F Cattabeni; C Martini
Journal:  Mol Pharmacol       Date:  2002-12       Impact factor: 4.436

2.  Molecular mechanisms of A3 adenosine receptor-induced G1 cell cycle arrest and apoptosis in androgen-dependent and independent prostate cancer cell lines: involvement of intrinsic pathway.

Authors:  Mahmoud Aghaei; Mojtaba Panjehpour; Fatemeh Karami-Tehrani; Siamak Salami
Journal:  J Cancer Res Clin Oncol       Date:  2011-08-10       Impact factor: 4.553

Review 3.  Purinoceptors on neuroglia.

Authors:  Alexei Verkhratsky; Alexei Verkhrasky; Oleg A Krishtal; Geoffrey Burnstock
Journal:  Mol Neurobiol       Date:  2009-03-13       Impact factor: 5.590

4.  Adenosine and deoxyadenosine induces apoptosis in oestrogen receptor-positive and -negative human breast cancer cells via the intrinsic pathway.

Authors:  M Hashemi; F Karami-Tehrani; S Ghavami; S Maddika; M Los
Journal:  Cell Prolif       Date:  2005-10       Impact factor: 6.831

5.  Effects of synthetic A3 adenosine receptor agonists on cell proliferation and viability are receptor independent at micromolar concentrations.

Authors:  Petr Mlejnek; Petr Dolezel; Ivo Frydrych
Journal:  J Physiol Biochem       Date:  2012-11-27       Impact factor: 4.158

6.  Impact of disrupting adenosine A₃ receptors (A₃⁻/⁻ AR) on colonic motility or progression of colitis in the mouse.

Authors:  Tianhua Ren; Iveta Grants; Mazin Alhaj; Matt McKiernan; Marlene Jacobson; Hamdy H Hassanain; Wendy Frankel; Jacqueline Wunderlich; Fievos L Christofi
Journal:  Inflamm Bowel Dis       Date:  2010-12-03       Impact factor: 5.325

Review 7.  Investigational A₃ adenosine receptor targeting agents.

Authors:  Balázs Koscsó; Balázs Csóka; Pál Pacher; György Haskó
Journal:  Expert Opin Investig Drugs       Date:  2011-04-02       Impact factor: 6.206

Review 8.  Adenosine receptor signaling in the brain immune system.

Authors:  György Haskó; Pál Pacher; E Sylvester Vizi; Peter Illes
Journal:  Trends Pharmacol Sci       Date:  2005-10       Impact factor: 14.819

9.  Adenosine induces cell cycle arrest and apoptosis via cyclinD1/Cdk4 and Bcl-2/Bax pathways in human ovarian cancer cell line OVCAR-3.

Authors:  Saeid Shirali; Mahmoud Aghaei; Mahdi Shabani; Mojtaba Fathi; Majid Sohrabi; Marzieh Moeinifard
Journal:  Tumour Biol       Date:  2013-01-24

10.  Behavioral characterization of mice lacking the A3 adenosine receptor: sensitivity to hypoxic neurodegeneration.

Authors:  Irina M Fedorova; Marlene A Jacobson; Anthony Basile; Kenneth A Jacobson
Journal:  Cell Mol Neurobiol       Date:  2003-06       Impact factor: 5.046

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.